From Policy Lag to Global Stage: How MSS Is Fast-Tracking Korea’s Biotech Ventures into Japan and the Nordics
Korea’s biotech ambitions are no longer confined to policy papers—they are being tested on the world stage. As the Ministry ...
KoreaTechDesk | Korean Startup and Technology News
Korea’s biotech ambitions are no longer confined to policy papers—they are being tested on the world stage. As the Ministry ...
Korea’s bio sector has emerged as the lone bright spot in an otherwise subdued venture market. Private investors are pouring ...
SN Bioscience (CEO Park Yung-hwan) released the phase 1 clinical trial result on SNB-101, a new anticancer medicine pipeline, at ...